BioCorRx Inc. announced the formation of its Scientific Advisory Board (SAB) with three key appointments: David R. Gastfriend, M.D., DFASAM, Evgeny Krupitsky M.D., Ph.D., D.M.Sc., and George E. Woody, M.D. The SAB will work closely with BioCorRx’s management team as it actively continues to advance its lead product candidate, BICX102. David R. Gastfriend, M.D., is a psychiatrist and internationally recognized addiction treatment researcher, policy expert and technology developer. Evgeny M. Krupitsky, M.D., Ph.D., D.M.Sc., serves as a Vice-Director for Research and the Chief of the Department of Addictions at Bekhterev National Medical Research Center for Psychiatry and Neurology and Chief of the Laboratory of Clinical Psychopharmacology of Addictions at St. Petersburg State Pavlov Medical University, Russia. George E. Woody, M.D., is Professor in the Department of Psychiatry at the University of Pennsylvania and Principal Investigator of the Delaware Valley Node of the NIDA Clinical Trials Network.